Iva Turudic

Iva Turudic

Company: Sanofi

Job title: Global Medical Launch & Alignment Lead Dermatology


Dupilumab: The First Approved Biologic for Atopic Dermatitis 3:20 pm

Shining light on the rationale for biologic development during a wave of JAK inhibitor development Transforming quality of life for patients by tackling chronic itch Looking forward into bringing dupilumab into other dermatological indicationsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.